Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 June 2025, 11:00 (CEST) to 17 June 2025, 12:00 (CEST)

Veterinary medicines European public assessment report (EPAR): Nobilis Multriva REOm, avian reovirus vaccine (inactivated), Status: Authorised

EMEA-003475-PIP01-23

Opinion/decision on a Paediatric investigation plan (PIP): Uplizna, Inebilizumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Nervous system disorders, PIP number: P/0471/2023

EMEA-003498-PIP01-23

Veterinary medicines European public assessment report (EPAR): Equilis Prequenza, vaccine against equine influenza in horses, Status: Authorised

EMEA-003466-PIP01-23

Veterinary medicines European public assessment report (EPAR): Equilis Te, Adjuvanted vaccine against tetanus, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Equilis Prequenza Te, vaccine against equine influenza and tetanus in horses, Status: Authorised

Minutes of the CHMP meeting 11-14 November 2024